RS
Roivant Sciences Ltd
🇺🇸XNAS.ROIVUnited StatesHealthcare
$39.77USDdown -1.25 (-3.05%)OpenEnd of day4:15 PM
Price$39.77-1.25 (-3.05%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- BMG762791017
- CUSIP
- G76279101
Company
- Employees
- 721
- Headquarters
- London, United States
- Website
- https://roivant.com
- CEO
- Dr. Eric Venker M.D., Pharm.D.
Market
- Shares outstanding
- 722.3M
- Market cap
- $28.73B
Key dates
- Next earnings
- Nov 9, 2026
Highlights
- Market cap
- $28.73B
- EPS LTM
- -$0.37
- P/E LTM
- -95.81
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $7.53M-67.58%down year on year
- Net income
- -$266.25M+45.73%up year on year
- Gross margin
- 81.21%-15.69%down year on year
- Free cash flow
- -$813.95M+5.21%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.